PVWM
BIIB icon

Point View Wealth Management’s Biogen BIIB Stock Holding History

Point View Wealth Management’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		$286K Sell
1,169
-129
-10% -$33.3K 0.12% 210
2020
Q3 		$368K Sell
1,298
-9
-0.7% -$2.51K 0.17% 165
2020
Q2 		$350K Buy
1,307
+10
+0.8% +$3.01K 0.17% 175
2020
Q1 		$410K Sell
1,297
-3
-0.2% -$910 0.22% 140
2019
Q4 		$386K Sell
1,300
-104
-7% -$28.9K 0.16% 181
2019
Q3 		$327K Buy
+1,404
New +$327K 0.15% 184

Other funds holding BIIB

Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Point View Wealth Management's BIIB Position: Q4 2020 in Review

Point View Wealth Management reduced its Biogen (BIIB) stake by 9.9% in Q4 2020, selling an estimated $33.3K and leaving 1,169 shares worth $286K. The position accounts for 0.12% of the portfolio, ranked #210.

Point View Wealth Management first reported a position in BIIB in Q3 2019 and has held it in 6 quarters since. The position peaked at $410K in Q1 2020. 1,061 funds tracked by Wall St. Rank hold BIIB as of Q4 2020.

  • Point View Wealth Management held 1,169 shares of Biogen worth $286K as of Q4 2020.
  • Point View Wealth Management sold 129 Biogen shares in Q4 2020, an estimated $33.3K.
  • Biogen made up 0.12% of Point View Wealth Management's portfolio in Q4 2020, its #210 holding.
  • Point View Wealth Management first reported a position in Biogen in Q3 2019 and has held it in 6 quarters since.
  • Point View Wealth Management's Biogen position peaked at $410K in Q1 2020.
  • 1,061 funds tracked by Wall St. Rank held Biogen as of Q4 2020.

Based on Point View Wealth Management's 13F filing for Q4 2020, filed 8 Feb 2021.